Drug Screening Market Size

  • Report ID: 4891
  • Published Date: Oct 14, 2024
  • Report Format: PDF, PPT

Drug Screening Market Size

Drug Screening Market size size was over USD 9.99 billion in 2024 and is projected to cross USD 105.01 billion by the end of 2037, growing at more than 19.6% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of drug screening is estimated at USD 11.57 billion.

The growth of the market can be propelled by the increasing prevalence of drug abuse, along with the growing demand for drug testing in various places. According to the data provided in World Drug Report 2021 by the United Nations Office on Drugs and Crime (UNODC), an estimated 275 million people worldwide used drugs at least once in the year 2020. This represents a 22% increase in the number of people who used drugs in the year 2010.

In addition to this, in terms of specific drugs, cannabis is the most commonly used drug worldwide. Moreover, the use of opioids, including heroin and prescription opioids, continues to be a major concern across the globe. Also, the non-medical use of prescription stimulants such as amphetamines is on the rise. Hence, drug tests can detect a wide range of drugs, including marijuana, cocaine, opioids, amphetamines, and others. They can be performed using different methods, such as urine, saliva, blood, and hair testing.


Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 4891
  • Published Date: Oct 14, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of drug screening is estimated at USD 11.57 billion.

The drug screening market size was over USD 9.99 billion in 2024 and is projected to cross USD 105.01 billion by the end of 2037, growing at more than 19.6% CAGR during the forecast period i.e., between 2025-2037. Increasing prevalence of drug abuse, and stringent government regulations will boost the market growth.

Asia Pacific industry is set to hold 24% of the revenue share till 2037, impelled by rising awareness about drug screening in the region.

The major players in the market include Quest Diagnostics, Laboratory Corporation of America Holdings (LabCorp), Thermo Fisher Scientific, Alere Inc., Siemens Healthineers, Shimadzu Corporation, F. Hoffmann-La Roche AG, Express Diagnostics International Inc., OraSure Technologies, Drägerwerk AG & Co. KGaA.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample